Cur(Que)min: A neuroactive permutation of Curcumin and Quercetin for treating spinal cord injury

Medical Hypotheses

Volumn 82, Issue 4, 2014, Pages 437-441

  Kumar, P ^a   Choonara, Y E ^a   Modi, G ^a   Naidoo, D ^a   Pillay, V ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; QUERCETIN;

ARTICLE; DRUG EFFECT; DRUG MECHANISM; HUMAN; HYPOTHESIS; NERVOUS SYSTEM INJURY; SPINAL CORD INJURY;

ANTIOXIDANTS; CURCUMIN; GLUTATHIONE TRANSFERASE; HUMANS; INFLAMMATION; MODELS, THEORETICAL; NEUROPROTECTIVE AGENTS; PHENOL; QUERCETIN; REACTIVE OXYGEN SPECIES; SPINAL CORD INJURIES; STEROIDS;

EID: 84896731992     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2014.01.019     Document Type: Article

References (61)

1. Hall E.D., Springer J.E. Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx 2004, 1:80-100.
2. Gupta R., Bathen M.E., Smith J.S., Levi A.D., Bhatia N.N., Steward O. Advances in the management of spinal cord injury. J Am Acad Orthop Surg 2010, 18:210-222.
3. Thuret S., Moon L.D., Gage F.H. Therapeutic interventions after spinal cord injury. Nat Rev Neurosci 2006, 7:628-643.
4. Sahin Kavakli H., Koca C., Alici O. Antioxidant effects of curcumin in spinal cord injury in rats. Ulus Travma Acil Cerrahi Derg 2011, 17(1):14-18.
5. Cemil B., Topuz K., Demircan M.N., et al. Curcumin improves early functional results after experimental spinal cord injury. Acta Neurochir (Wien) 2010, 152(9):1583-1590.
6. Lin M.S., Lee Y.H., Chiu W.T., Hung K.S. Curcumin provides neuroprotection after spinal cord injury. J Surg Res 2011, 166(2):280-289.
7. Ray B., Bisht S., Maitra A., Maitra A., Lahiri D.K. Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc™) in the neuronal cell culture and animal model: implications for Alzheimer's disease. J Alzheimers Dis 2011, 23(1):61-77.
8. Zbarsky V., Datla K.P., Parkar S., Rai D.K., Aruoma O.I., Dexter D.T. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radical Res 2005, 39(10):1119-1125.
9. Bishnoi M., Chopra K., Rongzhu L., Kulkarni S.K. Protective effect of curcumin and its combination with piperine (bioavailability enhancer) against haloperidol-associated neurotoxicity: cellular and neurochemical evidence. Neurotox Res 2011, 20(3):215-225.
10. Lin M.S., Sun Y.Y., Chiu W.T., et al. Curcumin attenuates the expression and secretion of RANTES after spinal cord injury in vivo and lipopolysaccharide-induced astrocyte reactivation in vitro. J Neurotrauma 2011, 28(7):1259-1269.
11. Schültke E., Kamencic H., Zhao M., et al. Neuroprotection following fluid percussion brain trauma: a pilot study using quercetin. J Neurotrauma 2005, 22(12):1475-1484.
12. Dok-Go H., Lee K.H., Kim H.J., et al. Neuroprotective effects of antioxidative flavonoids, quercetin, (+)-dihydroquercetin and quercetin 3-methyl ether, isolated from Opuntia ficus-indica var. saboten. Brain Res 2003, 965(1-2):130-136.
13. Schültke E., Griebel R.W., Juurlink B.H.J. Quercetin administration after spinal cord trauma changes S-100β levels. Can J Neurol Sci 2010, 37(2):223-228.
14. Schültke E., Griebel R.W., Juurlink B.H. Quercetin attenuates inflammatory processes after spinal cord injury in an animal model. Spinal Cord 2010, 48(12):857-861.
15. Schültke E., Kamencic H., Skihar V.M., Griebel R., Juurlink B. Quercetin in an animal model of spinal cord compression injury: correlation of treatment duration with recovery of motor function. Spinal Cord 2010, 48(2):112-117.
16. Zhang Z.J., Cheang L.C., Wang M.W., Lee S.M. Quercetin exerts a neuroprotective effect through inhibition of the iNOS/NO system and pro-inflammation gene expression in PC12 cells and in zebrafish. Int J Mol Med 2011, 27(2):195-203.
17. Schültke E., Kendall E., Kamencic H., Ghong Z., Griebel R.W., Juurlink B.H. Quercetin promotes functional recovery following acute spinal cord injury. J Neurotrauma 2003, 20(6):583-591.
18. Silva B., Oliveira P.J., Dias A., Malva J.O. Quercetin, kaempferol and biapigenin from Hypericum perforatum are neuroprotective against excitotoxic insults. Neurotox Res 2008, 13(3-4):265-279.
19. Cevik O., Erşahin M., Sener T.E., Tinay I., Tarcan T., Cetinel S., et al. Beneficial effects of quercetin on rat urinary bladder after spinal cord injury. J Surg Res 2013, 183(2):695-703.
20. Song Y., Liu J., Zhang F., Zhang J., Shi T., Zeng Z. Antioxidant effect of quercetin against acute spinal cord injury in rats and its correlation with the p38MAPK/iNOS signaling pathway. Life Sci 2013, 92(24-26):1215-1221.
21. Liu C., Shi Z., Fan L., Zhang C., Wang K., Wang B. Resveratrol improves neuron protection and functional recovery in rat model of spinal cord injury. Brain Res 2011, 16(1374):100-109.
22. Kiziltepe U., Turan N.N., Han U., Ulus A.T., Akar F. Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury. J Vasc Surg 2004, 40(1):138-145.
23. Kaplan S., Bisleri G., Morgan J.A., Cheema F.H., Oz M.C. Resveratrol, a natural red wine polyphenol, reduces ischemia-reperfusion-induced spinal cord injury. Ann Thoracic Surg 2005, 80(6):2242-2249.
24. Khalatbary A.R., Ahmadvand H. Neuroprotective effect of oleuropein following spinal cord injury in rats. Neurol Res 2012, 34(1):44-51.
25. Khalatbary A.R., Zarrinjoei G.R. Anti-inflammatory effect of oleuropein in experimental rat spinal cord trauma. Iran Red Crescent Med J 2012, 14(4):229-234.
26. Impellizzeri D., Esposito E., Mazzon E., et al. The effects of a polyphenol present in olive oil, oleuropein aglycone, in an experimental model of spinal cord injury in mice. Biochem Pharmacol 2012, 83(10):1413-1426.
27. Khalatbary A.R., Ahmadvand H. Anti-inflammatory effect of the epigallocatechin gallate following spinal cord trauma in rat. Iran Biomed J 2011, 15(1-2):31-37.
28. Khalatbary A.R., Tiraihi T., Boroujeni M.B., Ahmadvand H., Tavafi M., Tamjidipoor A. Effects of epigallocatechin gallate on tissue protection and functional recovery after contusive spinal cord injury in rats. Brain Res 2010, 1306:168-175.
29. Jackson J.K., Higo T., Hunter W.L., Burt H.M. The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis. Inflamm Res 2006, 55(4):168-175.
30. Yousef M.I., Omar S.A., El-Guendi M.I., Abdelmegid L.A. Potential protective effects of quercetin and curcumin on paracetamol-induced histological changes, oxidative stress, impaired liver and kidney functions and haematotoxicity in rat. Food Chem Toxicol 2010, 48(11):3246-3261.
31. Nabavi S.F., Moghaddam H.A., Nabavi S.M., Eslami S.H. Protective effect of curcumin and quercetin on thyroid function in sodium fluoride intoxicated rats. Fluoride 2011, 44(3):147-152.
32. Nesathurai S. Steroids and spinal cord injury: revisiting the NASCIS 2 and NASCIS 3 trials. J Trauma 1998, 45(6):1088-1093.
33. Kawanishi S., Oikawa S., Murata M. Evaluation for safety of antioxidant chemopreventive agents. Antioxid Redox Signal 2005, 7(11-12):1728-1739.
34. Moos P.J., Edes K., Mullally J.E., Fitzpatrick F.A. Curcumin impairs tumor suppressor p53 function in colon cancer cells. Carcinogenesis 2004, 25(9):1611-1617.
35. Burgos-Morón E., Calderón-Montaño J.M., Salvador J., Robles A., López-Lázaro M. The dark side of curcumin. Int J Cancer 2010, 126(7):1771-1775.
36. Dance-Barnes S.T., Kock N.D., Moore J.E., et al. Lung tumor promotion by curcumin. Carcinogenesis 2009, 30(6):1016-1023.
37. López-Lázaro M. Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. Mol Nutr Food Res 2008, 52(Suppl 1):S103-27.
38. Hsu C.H., Cheng A.L. Clinical studies with curcumin. Adv Exp Med Biol 2007, 595:471-480.
39. Jiao Y., Wilkinson J., Di X., et al. Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator. Blood 2009, 113(2):462-469.
40. Wu J.Y., Lin C.Y., Lin T.W., Ken C.F., Wen Y.D. Curcumin affects development of zebrafish embryo. Biol Pharm Bull 2007, 30(7):1336-1339.
41. Metodiewa D., Jaiswal A.K., Cenas N., Dickancaité E., Segura-Aguilar J. Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radical Biol Med 1999, 26(1-2):107-116.
42. Iwashita K., Kobori M., Yamaki K., Tsushida T. Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells. Biosci Biotechnol Biochem 2000, 64(9):1813-1820.
43. Cao X.G., Li X.X., Bao Y.Z., Xing N.Z., Chen Y. Responses of human lens epithelial cells to quercetin and DMSO. Invest Ophthalmol Vis Sci 2007, 48(8):3714-3718.
44. Dihal A.A., Woutersen R.A., Ommen B.V., Rietjens I.M., Stierum R.H. Modulatory effects of quercetin on proliferation and differentiation of the human colorectal cell line Caco-2. Cancer Lett 2006, 238(2):248-259.
45. Hirota S., Takahama U. Quercetin and the glucosides inhibit nitration of a salivary component 4-hydroxyphenylacetic acid catalyzed by salivary polymorphonuclear leukocytes. Food Sci Technol Res 2003, 9(4):378-382.
46. Blight A.R. Macrophages and inflammatory damage in spinal cord injury. J Neurotrauma 1992, 9:S83-91.
47. Saunders R., Horrocks L.A. Eicosanoids, plasma membranes, and molecular mechanisms of spinal cord injury. Neurochem Pathol 1987, 7(1):1-22.
48. Shen S.C., Lee W.R., Lin H.Y., et al. In vitro and in vivo inhibitory activities of rutin, wogonin, and quercetin on lipopolysaccharide-induced nitric oxide and prostaglandin E(2) production. Eur J Pharmacol 2002, 446(1-3):187-194.
49. Al-Fayez M., Cai H., Tunstall R., Steward W.P., Gescher A.J. Differential modulation of cyclooxygenase-mediated prostaglandin production by the putative cancer chemopreventive flavonoids tricin, apigenin and quercetin. Cancer Chemother Pharmacol 2006, 58(6):816-825.
50. Moon Y., Glasgow W.C., Eling T.E. Curcumin suppresses interleukin 1beta-mediated microsomal prostaglandin E synthase 1 by altering early growth response gene 1 and other signaling pathways. J Pharmacol Exp Ther 2005, 315(2):788-795.
51. Wang W., Huang C.Y., Tsai F.J., Tsai C.C., Yao C.H., Chen Y.S. Growth-promoting effects of quercetin on peripheral nerves in rats. Int J Artif Organs 2011, 34(11):1095-1105.
52. Khajavi M., Shiga K., Wiszniewski W., et al. Oral curcumin mitigates the clinical and neuropathologic phenotype of the Trembler-J mouse: a potential therapy for inherited neuropathy. Am J Hum Genet 2007, 81(3):438-453.
53. Toborek M., Malecki A., Garrido R., Mattson M.P., Hennig B., Young B. Arachidonic acid-induced oxidative injury to cultured spinal cord neurons. J Neurochem 1999, 73(2):684-692.
54. Bhaskar S., Shalini V., Helen A. Quercetin regulates oxidized LDL induced inflammatory changes in human PBMCs by modulating the TLR-NF-κB signaling pathway. Immunobiology 2011, 216(3):367-373.
55. Mascayano C., Núñez G., Acevedo W., Rezende M.C. Binding of arachidonic acid and two flavonoid inhibitors to human 12- and 15-lipoxygenases: a steered molecular dynamics study. J Mol Model 2010, 16(5):1039-1045.
56. Hong J., Bose M., Ju J., et al. Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis 2004, 25(9):1671-1679.
57. 2+ signaling. Biochem Pharmacol 1991, 58(7):1167-1172.
58. Kim H., Tator C.H., Shoichet M.S. Chitosan implants in the rat spinal cord: biocompatibility and biodegradation. J Biomed Mater Res A 2011, 97(4):395-404.
59. Chougala M.B., Bhaskar J.J., Rajan M.G., Salimath P.V. Effect of curcumin and quercetin on lysosomal enzyme activities in streptozotocin-induced diabetic rats. Clin Nutr 2012, 31(5):749-755.
60. Wang G., Wang L., Tang W., Hao X., Wang Y., Lu Y. Binding of quercetin to lysozyme as probed by spectroscopic analysis and molecular simulation. J Fluoresc 2011, 21(5):1879-1886.
61. Wang S.S., Liu K.N., Lee W.H. Effect of curcumin on the amyloid fibrillogenesis of hen egg-white lysozyme. Biophys Chem 2009, 144(1-2):78-87.